Praxair Distribution, Inc.
Oxygen
FULL PRESCRIBING INFORMATION
UN1072 OXYGEN, COMPRESSED USP
WARNING! HIGH-PRESSURE, OXIDIZING GAS. VIGOROUSLY ACCELERATES COMBUSTION. Keep oil, grease and combustibles away. Keep away from heat, sparks and flame. Store and use with adequate ventilation to prevent oxygen accumulation. Use with equipment rated for cylinder pressure and cleaned for oxygen service. Use a backflow prevention device in any piping. Cylinder temperature should not exceed 125 deg F (52 deg C). Open valve slowly. Close valve after each use; keep closed even when empty. Always secure cylinder. Install cap, if provided, when not in use. Use per Praxair MSDS form P-4638 and safety booklets P-3499, P-14-153, and P-15-276; obtain from your local supplier. KEEP OUT OF REACH OF CHILDREN. WARNING! For emergency use only when administered by properly trained personnel for oxygen deficiency and resuscitation. For all other medical applications, Rx ONLY.
Uninterrupted use of high concentrations of oxygen over a long duration, without monitoring its effects on oxygen content of arterial blood, may be harmful. Use only with pressure reducing equipment and apparatus designed for oxygen. Do not attempt to use on patients who have stopped breathing unless used in conjunction with resuscitative equipment.
Rx ONLY CAS 7782-44-7 PRODUCED BY AIR LIQUEFACTION
IN CASE OF EMERGENCY: CALL 1-800-645-4633
DISTRIBUTED BY PRAXAIR, INC., DANBURY
DO NOT REMOVE THIS LABEL PMG-6 (07/08)
Praxair, the flowing airstream design and Medipure are trademarks of Praxair Technology, Inc. DISTRIBUTED BY PRAXAIR, INC, DANBURY, CT 06810-5113
DISTRIBUTED BY PRAXAIR, INC., DANBURY
UN1072 OXYGEN, COMPRESSED USP
DANGER! COMPRESSED, OXIDIZING GAS. MAY CAUSE OR INTENSIFY FIRE; OXIDIZER. CONTAINS GAS UNDER PRESSURE; MAY EXPLODE IF HEATED. Keep/store away from
combustible materials. Keep reduction valves free from grease and oil. In case of fire: stop leak if safe to do so. Open valve slowly. Close valve after each use and when empty. Use only with equipment cleaned for oxygen service and rated for cylinder pressure. Use a backflow preventive device in the piping. Protect from sunlight when ambient temperature exceeds 52 deg C/125 deg F. Cylinder temperature should not exceed 52 deg C/125 deg F. Store and use in a well-ventilated place. Use per Praxair MSDS form P-4638, and safety booklets P-3499, P-14-153, and P-15-276; obtain from your local supplier. KEEP OUT OF REACH OF CHILDREN. Do not handle until all safety precautions have been read and understood.
WARNING! For emergency use only when administered by properly trained personnel for oxygen deficiency and resuscitation. For all other medical applications, Rx ONLY.
Uninterrupted use of high concentrations of oxygen over a long duration, without monitoring its effects on oxygen content of arterial blood, may be harmful. Use only with pressure reducing equipment and apparatus designed for oxygen. Do not attempt to use on patients who have stopped breathing unless used in conjunction with resuscitative equipment
DO NOT REMOVE THIS LABEL
Rx ONLY CAS 7782-44-7 PRODUCED BY AIR LIQUEFACTION
IN CASE OF EMERGENCY: CALL 1-800-645-4633
DISTRIBUTED BY PRAXAIR, INC., DANBURY
PMGB-6 (03/11)
Praxair, the flowing airstream design and Medipure are trademarks of Praxair Technology, Inc. DISTRIBUTED BY PRAXAIR, INC, DANBURY, CT 06810-5113
UN1073 OXYGEN, REFRIGERATED LIQUID USP
ALWAYS KEEP CONTAINER IN UPRIGHT POSITION. DO NOT CHANGE OR FORCE-FIT CONNECTIONS
LOT #
NET CONTENTS
WARNING! EXTREMELY COLD, OXIDIZING LIQUID AND GAS UNDER PRESSURE. VIGOROUSLY ACCELERATES COMBUSTION. COMBUSTIBLES IN CONTACT WITH
LIQUID OXYGEN MAY EXPLODE ON IGNITION OR IMPACT. CAN CAUSE SEVERE FROSTBITE. MAY CAUSE DIZZINESS OR DROWSINESS. ODOR: NONE
Do not drop. Use suitable hand truck for container movement. Keep oil, grease, and combustibles away. Keep away from heat, sparks, and flame. Use with equipment cleaned for oxygen service. Do not get liquid in eyes, on skin, or clothing. For liquid withdrawal, wear face shield and gloves. Avoid spills. Do not walk on or roll equipment over spills. Store and use with adequate ventilation to prevent oxygen accumulation. Container temperature should not exceed 125 deg F (52 deg C). Use piping
and equipment adequately designed to withstand any pressures to be encountered. Use a backflow prevention device in any piping. Close valve after each use; keep closed even when empty. Container discharge must be warmed to room temperature before breathing. Always secure container so it cannot be knocked over. Use per Praxair MSDS form P-4637 and safety booklets P-3499, P-14-153, and P-15-276 (obtain from your local supplier), and per manufacturer’s instructions for this container.
RX ONLY
FIRST AID: INHALATION—immediately remove to fresh air. If not breathing, give artificial respiration. Keep victim warm and at rest. Call a physician. Advise physician that the victim has
been exposed to a high concentration of oxygen. FROSTBITE—Obtain medical treatment immediately. FOR SKIN CONTACT, immediately warm frostbite area with warm water not exceeding 105 deg F (41 deg C). In case of massive exposure, remove clothing while showering with warm water. Call a physician. FOR EYE CONTACT, flush eyes with warm water for at least 15 minutes. See a physician, preferably an ophthalmologist, immediately.
WARNING: For emergency use only when administered by properly trained personnel for oxygen deficiency and resuscitation. For all other medical applications, Rx ONLY. Uninterrupted use of high concentrations of oxygen over a long duration, without monitoring its effects on oxygen content of arterial blood, may be harmful. Use only with pressure reducing equipment and apparatus designed for oxygen. Do not attempt to use on patients who have stopped breathing unless used in conjunction with resuscitative equipment.
DO NOT REMOVE THIS LABEL
Rx ONLY CAS 7782-44-7 PRODUCED BY AIR LIQUEFACTION
IN CASE OF EMERGENCY: CALL 1-800-645-4633
PMG-8 (07/08)
Copyright @ 2002-2003, 2008. Praxair Technology, Inc.Praxair, the flowing airstream design and Medipure are trademarks of Praxair Technology, Inc. DISTRIBUTED BY PRAXAIR, INC, DANBURY, CT 06810-5113
Product Information
|
Product Type
|
Human prescription drug label |
Item Code (Source)
|
NDC:59579-001 |
Route of Administration
|
RESPIRATORY (INHALATION) |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
Oxygen Oxygen |
|
990 mL
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:59579-001-01 |
16424 in 1 CYLINDER |
|
|
2 |
NDC:59579-001-02 |
14130 in 1 CYLINDER |
|
|
3 |
NDC:59579-001-03 |
10987 in 1 CYLINDER |
|
|
4 |
NDC:59579-001-04 |
9543 in 1 CYLINDER |
|
|
5 |
NDC:59579-001-05 |
7985 in 1 CYLINDER |
|
|
6 |
NDC:59579-001-06 |
7051 in 1 CYLINDER |
|
|
7 |
NDC:59579-001-07 |
4361 in 1 CYLINDER |
|
|
8 |
NDC:59579-001-08 |
3511 in 1 CYLINDER |
|
|
9 |
NDC:59579-001-09 |
2350 in 1 CYLINDER |
|
|
10 |
NDC:59579-001-10 |
708 in 1 CYLINDER |
|
|
11 |
NDC:59579-001-11 |
595 in 1 CYLINDER |
|
|
12 |
NDC:59579-001-12 |
425 in 1 CYLINDER |
|
|
13 |
NDC:59579-001-13 |
142 in 1 CYLINDER |
|
|
14 |
NDC:59579-001-14 |
198 in 1 CYLINDER |
|
|
15 |
NDC:59579-001-15 |
7730 in 1 CYLINDER |
|
|
16 |
NDC:59579-001-16 |
4332 in 1 CYLINDER |
|
|
17 |
NDC:59579-001-17 |
2520 in 1 CYLINDER |
|
|
18 |
NDC:59579-001-18 |
934 in 1 CYLINDER |
|
|
19 |
NDC:59579-001-19 |
680 in 1 CYLINDER |
|
|
20 |
NDC:59579-001-20 |
142 in 1 CYLINDER |
|
|
21 |
NDC:59579-001-23 |
74566 in 1 DEWAR |
|
|
22 |
NDC:59579-001-24 |
103757 in 1 DEWAR |
|
|
23 |
NDC:59579-001-25 |
114228 in 1 DEWAR |
|
|
24 |
NDC:59579-001-26 |
120574 in 1 DEWAR |
|
|
25 |
NDC:59579-001-27 |
127237 in 1 DEWAR |
|
|
26 |
NDC:59579-001-28 |
135487 in 1 DEWAR |
|
|
27 |
NDC:59579-001-29 |
142785 in 1 DEWAR |
|
|
28 |
NDC:59579-001-30 |
155794 in 1 DEWAR |
|
|
29 |
NDC:59579-001-31 |
162140 in 1 DEWAR |
|
|
30 |
NDC:59579-001-32 |
178957 in 1 DEWAR |
|
|
31 |
NDC:59579-001-33 |
291916 in 1 DEWAR |
|
|
32 |
NDC:59579-001-34 |
428355 in 1 DEWAR |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
NDA |
NDA205849 |
2007-10-01 |
|
|